Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Study finds fruit juice may reduce Alzheimer’s risk
The study, conducted by Dr Qi Dai, assistant professor of Medicine at Vanderbilt University Medical Center, and colleagues, appears in the September issue of The American Journal of
The study, conducted by Dr Qi Dai, assistant professor of Medicine at Vanderbilt University Medical Center, and colleagues, appears in the September issue of The American Journal of
The drug was shown to decrease a number of inflammatory proteins. Because inflammatory proteins play a critical role in inflammation and drive the inflammatory response to disease, controlling
AnorMed's lead product, Mozibil, is currently in a phase III trial in multiple myeloma, and a second phase III trial in non-Hodgkin's lymphoma. Dr Joe Dougherty, chairman of
The study will focus on “vulnerable” plaque, a lipid-rich coronary plaque that suddenly ruptures, believed to be the cause of most heart attacks. The study enrolled 700 acute
The collaboration expands on a previously announced project in which the companies sought to validate the use of Immunetrics in silico models of inflammation in predicting the outcomes
The decision, following a portfolio review at Roche, has no effect on the companies’ ongoing collaboration to co-develop daclizumab in transplant maintenance, and the companies intend to proceed
Enrollment in both trials has significantly outpaced the company’s expectations. As a result its clinical research organizations are still in the process of allocating the resources required to
In the preclinical studies, the active compound was able to inhibit the varicella zoster virus (the root cause of shingles) much more quickly than acyclovir, which is marketed
“This NIA grant allows us to significantly advance our understanding of how genes and their protein-products work together inside a cell to bring about bone formation,” said Velcura’s
Short hairpin RNA (shRNA) is useful where long-term gene suppression is required, or where the cells are resistant to other delivery methods. Its use, however, has been limited